For cases that are CD10-negative, testing for BCL6 and MUM1 is necessary, as nearly 75% and 50% of DLBCL cases test positive for BCL6 and MUM1, respectively. The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.